JP2009506762A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506762A5 JP2009506762A5 JP2008528437A JP2008528437A JP2009506762A5 JP 2009506762 A5 JP2009506762 A5 JP 2009506762A5 JP 2008528437 A JP2008528437 A JP 2008528437A JP 2008528437 A JP2008528437 A JP 2008528437A JP 2009506762 A5 JP2009506762 A5 JP 2009506762A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cell
- nucleic acid
- seq
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 34
- 206010028980 Neoplasm Diseases 0.000 claims 17
- 210000004027 cell Anatomy 0.000 claims 15
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 12
- 150000007523 nucleic acids Chemical class 0.000 claims 12
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 11
- 108091008874 T cell receptors Proteins 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 239000013604 expression vector Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 7
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims 6
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 1
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 1
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 229940022399 cancer vaccine Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940047120 colony stimulating factors Drugs 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 108010028930 invariant chain Proteins 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05019255A EP1760089B1 (en) | 2005-09-05 | 2005-09-05 | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
| EP05019255.8 | 2005-09-05 | ||
| PCT/EP2006/008641 WO2007028573A1 (en) | 2005-09-05 | 2006-09-05 | Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506762A JP2009506762A (ja) | 2009-02-19 |
| JP2009506762A5 true JP2009506762A5 (OSRAM) | 2009-07-16 |
| JP5132561B2 JP5132561B2 (ja) | 2013-01-30 |
Family
ID=35149455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528437A Expired - Fee Related JP5132561B2 (ja) | 2005-09-05 | 2006-09-05 | ヒト白血球抗原（ｈｌａ）クラスｉまたはｉｉ分子に結合する腫瘍関連ペプチドおよび関連する抗癌ワクチン |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090274714A1 (OSRAM) |
| EP (2) | EP1760089B1 (OSRAM) |
| JP (1) | JP5132561B2 (OSRAM) |
| KR (1) | KR101150663B1 (OSRAM) |
| CN (1) | CN101287755B (OSRAM) |
| AT (2) | ATE440107T1 (OSRAM) |
| AU (1) | AU2006289289B2 (OSRAM) |
| BR (1) | BRPI0615466A2 (OSRAM) |
| CA (1) | CA2621414C (OSRAM) |
| CY (2) | CY1110536T1 (OSRAM) |
| DE (2) | DE602005016112D1 (OSRAM) |
| DK (2) | DK1760089T3 (OSRAM) |
| EA (1) | EA013466B1 (OSRAM) |
| ES (2) | ES2330013T3 (OSRAM) |
| HR (1) | HRP20110240T1 (OSRAM) |
| NO (1) | NO20081690L (OSRAM) |
| NZ (1) | NZ565956A (OSRAM) |
| PL (2) | PL1760089T3 (OSRAM) |
| PT (2) | PT1760089E (OSRAM) |
| RS (1) | RS51893B (OSRAM) |
| SI (2) | SI1760089T1 (OSRAM) |
| UA (2) | UA105210C2 (OSRAM) |
| WO (1) | WO2007028573A1 (OSRAM) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE461215T1 (de) * | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| ES2321680B1 (es) * | 2007-04-26 | 2010-03-05 | Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental - Alejandro Otero (Fibao) | Restauracion de las moleculas hla de clase i mediante terapia genica empleando vectores adenovirales portando el gen de la beta 2-microglobulina. |
| HUE027057T2 (en) | 2007-07-27 | 2016-08-29 | Immatics Biotechnologies Gmbh | New immunogenic epitope for immunotherapy |
| CN103911358B (zh) | 2007-07-27 | 2017-03-01 | 伊玛提克斯生物技术有限公司 | 神经元和脑肿瘤的新型免疫疗法 |
| JP5352586B2 (ja) * | 2007-07-27 | 2013-11-27 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 腫瘍関連ペプチドおよび関連抗癌ワクチンの組成物 |
| CY1112212T1 (el) * | 2008-04-24 | 2015-12-09 | Immatics Biotechnologies Gmbh | Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια |
| PL2113253T3 (pl) * | 2008-04-30 | 2010-09-30 | Immatics Biotechnologies Gmbh | Nowa postać leku - preparat zawierający peptydy nowotworowe wiążące się z antygenami ludzkich leukocytów klasy I i II, zastosowany w szczepionce |
| HUE024541T2 (hu) | 2008-05-14 | 2016-01-28 | Immatics Biotechnologies Gmbh | Szurvivinbõl és neurocanból származó új és hatásos II-es osztályú MHC peptidek |
| PL2172211T3 (pl) * | 2008-10-01 | 2015-05-29 | Immatics Biotechnologies Gmbh | Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka |
| AU2016204712B2 (en) * | 2008-10-01 | 2018-03-01 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201009222D0 (en) * | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| UA110119C2 (xx) * | 2010-12-02 | 2015-11-25 | Пептиди tomm34 та вакцини, що їх містять | |
| EP2729166B1 (en) * | 2011-07-05 | 2017-09-06 | Cadila Pharmaceuticals Limited | Cancer antigen |
| MY170949A (en) * | 2011-07-11 | 2019-09-20 | Cancer Res Initiatives Foundation | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| US10900072B2 (en) | 2012-06-27 | 2021-01-26 | Rutgers, The State University Of New Jersey | Rapid assays for T-cell activation by RNA measurements using flow cytometry |
| US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
| TWI636065B (zh) * | 2013-08-05 | 2018-09-21 | 伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| US9775892B2 (en) | 2013-12-09 | 2017-10-03 | Targovax Asa | Peptide mixture |
| MA49157A (fr) | 2014-12-23 | 2021-06-02 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| US11001830B2 (en) * | 2015-03-16 | 2021-05-11 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library |
| TWI755158B (zh) | 2015-03-17 | 2022-02-11 | 德商英麥提克生物技術股份有限公司 | 用於抗胰臟癌與其他癌症的免疫治療的新穎胜肽及胜肽的組合 |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| RS64397B1 (sr) | 2015-03-27 | 2023-08-31 | Immatics Biotechnologies Gmbh | Novi peptidi i kombinacija peptida za upotrebu u imunoterapiji protiv raznih tumora (seq id 25 - mrax5-003) |
| GB201505585D0 (en) * | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| GB201510771D0 (en) | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| TWI747524B (zh) | 2015-06-19 | 2021-11-21 | 德商英麥提克生物技術股份有限公司 | 用於免疫治療的新穎胜肽及胜肽組合物與產生用於抗胰臟癌及其他癌症的支架的方法 |
| HK1254866A1 (zh) | 2015-06-25 | 2019-07-26 | Immatics Biotechnologies Gmbh | 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物 |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| EP3919507A3 (en) | 2015-07-01 | 2022-01-12 | Immatics Biotechnologies GmbH | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201511792D0 (en) | 2015-07-06 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers |
| PT3319985T (pt) | 2015-07-06 | 2021-01-06 | Immatics Biotechnologies Gmbh | Novos péptidos e combinação de péptidos para uso em imunoterapia do cancro do esófago e outros cancros |
| GB201512369D0 (en) * | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| PH12022551111A1 (en) | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201517538D0 (en) | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| EP3167898A1 (en) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Method for obtaining tumor peptides and uses thereof |
| EP3383427A4 (en) * | 2015-12-04 | 2019-11-27 | Mayo Foundation for Medical Education and Research | METHOD AND VACCINES FOR INDUCTION OF IMMUNE REACTIONS TO SEVERAL DIFFERENT MHC MOLECULES |
| HK1255541A1 (zh) | 2015-12-11 | 2019-08-23 | Immatics Biotechnologies Gmbh | 用於多种癌症免疫治疗的新型肽和肽组合物 |
| GB201521894D0 (en) * | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| EP3419656A4 (en) * | 2016-02-22 | 2019-10-30 | Oceanside Biotechnology | NEOANTIGEN COMPOSITIONS AND METHODS FOR USE THEREOF IN IMMUNOOTHERAPY |
| US20190307868A1 (en) * | 2016-03-31 | 2019-10-10 | Neon Therapeutics, Inc. | Neoantigens and methods of their use |
| TW202304970A (zh) * | 2016-08-26 | 2023-02-01 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| KR102379955B1 (ko) | 2016-12-08 | 2022-03-29 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| CN106986932A (zh) * | 2017-04-06 | 2017-07-28 | 海口市人民医院 | 一种c‑Met表位肽及其应用 |
| JP6857930B2 (ja) * | 2018-02-15 | 2021-04-14 | 国立大学法人旭川医科大学 | がん抗原ペプチド |
| CN110804642B (zh) * | 2019-09-10 | 2022-06-21 | 清华大学 | Gpr174免疫学功能及其用途 |
| JP7668549B2 (ja) * | 2019-11-14 | 2025-04-25 | ボアズィチ ウニヴェルシテシ | がん免疫療法におけるａｓｃスペック |
| CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术（广东）有限公司 | 源自于ssx2抗原的短肽 |
| US20240358808A1 (en) * | 2021-04-23 | 2024-10-31 | Flow Pharma, Inc. | Vaccine for sars-cov-2 |
| CN118620040A (zh) * | 2022-01-05 | 2024-09-10 | 成都朗谷生物科技股份有限公司 | 一种针对乙型肝炎病毒的抗原肽 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| NZ192465A (en) | 1978-12-22 | 1983-09-30 | Biogen Nv | Recombinant dna molecule comprising gene coding for polypeptide displaying hbv (hepatitis b virus) antigenicity usesthereof |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| EP0769963A4 (en) | 1994-07-27 | 1999-07-28 | Commw Scient Ind Res Org | POLYEPITOPE VACCINES |
| ATE244300T1 (de) | 1996-01-17 | 2003-07-15 | Imp College Innovations Ltd | Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl) |
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| KR100358068B1 (ko) * | 1999-12-28 | 2002-10-25 | 주식회사 하이닉스반도체 | 플래쉬 메모리 소자의 제조방법 |
| WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| US20060045881A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
-
2005
- 2005-09-05 ES ES05019255T patent/ES2330013T3/es not_active Expired - Lifetime
- 2005-09-05 PL PL05019255T patent/PL1760089T3/pl unknown
- 2005-09-05 SI SI200530796T patent/SI1760089T1/sl unknown
- 2005-09-05 EP EP05019255A patent/EP1760089B1/en not_active Expired - Lifetime
- 2005-09-05 DK DK05019255T patent/DK1760089T3/da active
- 2005-09-05 AT AT05019255T patent/ATE440107T1/de active
- 2005-09-05 PT PT05019255T patent/PT1760089E/pt unknown
- 2005-09-05 DE DE602005016112T patent/DE602005016112D1/de not_active Expired - Lifetime
-
2006
- 2006-09-05 WO PCT/EP2006/008641 patent/WO2007028573A1/en not_active Ceased
- 2006-09-05 UA UAA201111468A patent/UA105210C2/ru unknown
- 2006-09-05 AT AT06777167T patent/ATE494303T1/de active
- 2006-09-05 UA UAA200803781A patent/UA97095C2/ru unknown
- 2006-09-05 PT PT06777167T patent/PT1922334E/pt unknown
- 2006-09-05 DE DE602006019446T patent/DE602006019446D1/de active Active
- 2006-09-05 SI SI200630949T patent/SI1922334T1/sl unknown
- 2006-09-05 AU AU2006289289A patent/AU2006289289B2/en not_active Ceased
- 2006-09-05 EP EP06777167A patent/EP1922334B1/en active Active
- 2006-09-05 US US12/065,725 patent/US20090274714A1/en not_active Abandoned
- 2006-09-05 RS RS20110146A patent/RS51893B/sr unknown
- 2006-09-05 DK DK06777167.5T patent/DK1922334T3/da active
- 2006-09-05 CN CN200680038407.7A patent/CN101287755B/zh not_active Expired - Fee Related
- 2006-09-05 EA EA200800676A patent/EA013466B1/ru not_active IP Right Cessation
- 2006-09-05 BR BRPI0615466-2A patent/BRPI0615466A2/pt not_active IP Right Cessation
- 2006-09-05 HR HR20110240T patent/HRP20110240T1/xx unknown
- 2006-09-05 PL PL06777167T patent/PL1922334T3/pl unknown
- 2006-09-05 JP JP2008528437A patent/JP5132561B2/ja not_active Expired - Fee Related
- 2006-09-05 NZ NZ565956A patent/NZ565956A/en not_active IP Right Cessation
- 2006-09-05 ES ES06777167T patent/ES2358802T3/es active Active
- 2006-09-05 KR KR1020087008126A patent/KR101150663B1/ko not_active Expired - Fee Related
- 2006-09-05 CA CA2621414A patent/CA2621414C/en not_active Expired - Fee Related
-
2008
- 2008-04-04 NO NO20081690A patent/NO20081690L/no not_active Application Discontinuation
-
2009
- 2009-10-08 CY CY20091101040T patent/CY1110536T1/el unknown
-
2011
- 2011-03-11 CY CY20111100271T patent/CY1113062T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009506762A5 (OSRAM) | ||
| JP2017525336A5 (OSRAM) | ||
| JP2021168652A5 (OSRAM) | ||
| TWI517859B (zh) | 癌抗原輔助肽 | |
| JP2010534463A5 (OSRAM) | ||
| JP2024099580A5 (OSRAM) | ||
| JP2017524337A5 (OSRAM) | ||
| JP2020198875A5 (OSRAM) | ||
| JP2020191862A5 (OSRAM) | ||
| JP2024041841A5 (OSRAM) | ||
| JP2020182458A5 (OSRAM) | ||
| HRP20100128T1 (hr) | Tumoru pridruženi peptid koji se slobodno veže na molekule humanog leukocitnog antigena (hla) klase ii | |
| JP2018511321A5 (OSRAM) | ||
| JP2019502360A5 (OSRAM) | ||
| ME02692B (me) | NOVA IMUNOTERAPIJA PROTIV NEKOLIKO TUMORA UKLJUČUJUĆI GASTROINTESTINALNI KARCINOM l KARCINOM ŽELUCA | |
| CN103570818B (zh) | 肿瘤抗原性多肽及其作为肿瘤疫苗的用途 | |
| JP2018509135A5 (OSRAM) | ||
| JP2018510628A5 (OSRAM) | ||
| JP2019510465A5 (OSRAM) | ||
| JP2018529320A5 (OSRAM) | ||
| JP2018521641A5 (OSRAM) | ||
| JP2019506838A5 (OSRAM) | ||
| JP2018520653A5 (OSRAM) | ||
| JP2018536383A5 (OSRAM) | ||
| US20230096433A1 (en) | Fractal Combination Therapy |